Roost, M. S., Potthast, H., Walther, C., García-Arieta, A., Abalos, I., Fernandes, E. A. F., . . . Braddy, A. (2021). Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities. Canadian Society for Pharmaceutical Sciences.
Cita Chicago Style (17a ed.)Roost, Matthias Shona, et al. Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities. Canadian Society for Pharmaceutical Sciences, 2021.
Cita MLA (8a ed.)Roost, Matthias Shona, et al. Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities. Canadian Society for Pharmaceutical Sciences, 2021.